PIERRI, IVANA

PIERRI, IVANA  

100007 - Dipartimento di Medicina interna e specialità mediche  

Mostra records
Risultati 1 - 20 di 79 (tempo di esecuzione: 0.005 secondi).
Titolo Data di pubblicazione Autore(i) File
Abnormalities of T cells isolated from mediastinal lymph nodes and peripheral blood of patients with lung carcinoma: deficit in PHA-induced expression of HLA class II antigens and in autologous mixed lymphocyte reactions. 1-gen-1986 Indiveri, F; Pierri, Ivana; Rogna, S; Poggi, A; Romano, R; Tavano, A; Ratto, G; Motta, G; Ferrone, S.
Acute tuberculous septicemia. 1-gen-1984 Pesce, Carlo; Pierri, Ivana
Adding low-dose gemtuzumab ozogamicin to fludarabine, Ara-C and idarubicin (MY-FLAI) may improve disease-free and overall survival in elderly patients with non-M3 acute myeloid leukaemia: results of a prospective, pilot, multi-centre trial and comparison with a historical cohort of patients 1-gen-2007 Clavio, M.; Vignolo, L.; Albarello, A.; Varaldo, R.; Pierri, Ivana; Catania, G.; Balocco, M.; Michelis, G.; Miglino, Maurizio; Manna, A.; Balleari, E.; Carella, A. M.; Sessarego, Mario; VAN LINT, M. T.; Bacigalupo, A.; Gobbi, Marco
The addition of radiotherapy to chemotherapy does not improve outcome of early stage Hodgkin's lymphoma patients: a retrospective long-term follow-up analysis of a regional Italian experience. 1-gen-2009 Olcese, F; Clavio, M; Rossi, E; Spriano, M; Ballerini, F; Canepa, L; Pierri, Ivana; Aquino, S; Varaldo, R; Manna, A; Secondo, V; Racchi, O; Balleari, E; Orcioni, Gf; Carella, Am; Ghio, Riccardo; Gobbi, Marco
Age and dPCR can predict relapse in CML patients who discontinued imatinib: The ISAV study 1-gen-2015 Mori, S.; Vagge, E.; Le Coutre, P.; Abruzzese, E.; Martino, B.; Pungolino, E.; Elena, C.; Pierri, I.; Assouline, S.; D'Emilio, A.; Gozzini, A.; Giraldo, P.; Stagno, F.; Iurlo, A.; Luciani, M.; De Riso, G.; Redaelli, S.; Kim, D. -W.; Pirola, A.; Mezzatesta, C.; Petroccione, A.; Lodolo D'Oria, A.; Crivori, P.; Piazza, R.; Gambacorti-Passerini, C.
Allogeneic bone marrow transplantation (BMT) for adults with acute lymphoblastic leukemia (ALL): predictive role of minimal residual disease monitoring on relapse 1-gen-2002 Miglino, Maurizio; Berisso, G; Grasso, R; Canepa, L; Verdiani, Simonetta; Clavio, M; Pierri, Ivana; Pietrasanta, D; Gatto, S; Varaldo, R; Ballerini, F; Verdiani, S; Casarino, L; Destefano, F; Sessarego, Mario; Dominietto, A; Raiola, Am; Bregante, S; DI GRAZIA, C; Gobbi, Marco; Bacigalupo, A.
An unusual reaction to alpha interferon in a case of non Hodgkin's lymphoma. 1-gen-1993 Miglino, Maurizio; Pierri, Ivana; Canepa, L; Carrara, P; Celesti, L; Gobbi, Marco
Analysis of the receptor-ligand interactions in the natural killer-mediated lysis of freshly isolated myeloid or lymphoblastic leukemias: evidence for the involvement of the Poliovirus receptor (CD155) and Nectin-2 (CD112) 1-gen-2005 Pende, D.; Spaggiari, GRAZIA MARIA; Marcenaro, S.; Martini, S.; Rivera, P.; Capobianco, A.; Falco, M.; Lanino, E.; Pierri, Ivana; Zambello, R.; Bacigalupo, A.; Mingari, MARIA CRISTINA; Moretta, Alessandro; Moretta, Lorenzo
Analysis of the role of xenogeneic antigens in the proliferation of human T cells stimulated with autologous non-T cells and phytohemagglutinin-activated T cells. 1-gen-1985 Indiveri, F; Scudeletti, M; Pende, D; Piccardo, C; Pierri, Ivana; Ferrone, S.
ANTITUMOR ACTIVITY OF NAMPT INHIBITION AND SYNERGY WITH CYCLOSPORIN A AND HDACIS TO PROMOTE APOPTOSIS IN PRIMARY LEUKEMIC CELLS 1-gen-2009 Cea, Mc; Cagnetta, Antonia; Garuti, Anna; Zoppoli, Gabriele; Rocco, Ilaria; Moran, Eva; Ballestrero, Alberto; Pierri, Ivana; Gobbi, Marco; Nencioni, Alessio; Patrone, Franco
APO866 activity in hematologic malignancies: a preclinical in vitro study. 1-gen-2009 Cea, Michele; Zoppoli, Gabriele; Bruzzone, Santina; Fruscione, Floriana; Moran, Eva; Garuti, Anna; Rocco, Ilaria; Cirmena, Gabriella; Casciaro, S; Olcese, F; Pierri, Ivana; Cagnetta, Antonia; Ferrando, Fabio; Ghio, Riccardo; Gobbi, Marco; Ballestrero, Alberto; Patrone, Franco; Nencioni, Alessio
APO866 increases antitumor activity of cyclosporin - A by inducing mitochondrial and endoplasmic reticulum stress in leukemia cells 1-gen-2015 Cagnetta, Antonia; Caffa, Irene; Acharya, Chirag; Soncini, Debora; Acharya, Prakrati; Adamia, Sophia; Pierri, Ivana; Bergamaschi, Micaela; Garuti, Anna; Fraternali, Giulio; Mastracci, Luca; Provenzani, Alessandro; Zucal, Chiara; Damonte, Gianluca; Salis, Annalisa; Montecucco, Fabrizio; Patrone, Franco; Ballestrero, Alberto; Bruzzone, Santina; Gobbi, Marco; Nencioni, Alessio; Cea, Michele
Case-control study of multidrug resistance phenotype and response to induction treatment including or not fludarabine in newly diagnosed acute myeloid leukaemia patients 1-gen-2007 Malagola, M.; Damiani, D.; Martinelli, G.; Michelutti, A.; Cesana, B.; Vivo, A. D.; Piccaluga, P. P.; Ottaviani, E.; Candoni, A.; Geromin, A.; Tiribelli, M.; Fanin, R.; Testoni, N.; Lauria, F.; Bocchia, M.; Gobbi, Marco; Pierri, Ivana; Zaccaria, A.; Zuffa, E.; Mazza, P.; Priccolo, G.; Gugliotta, L.; Bonini, A.; Visani, G.; Skert, C.; Bergonzi, C.; Roccaro, A. M.; Filí, C.; Baccarani, M.; Russo, D.
Chronic lymphocytic leukemia nurse-like cells express hepatocyte growth factor receptor (c-MET) and indoleamine 2,3-dioxygenase and display features of immunosuppressive type 2 skewed macrophages 1-gen-2014 Giannoni, Paolo; Pietra, Gabriella; G., Travaini; Quarto, Rodolfo; G., Shyti; R., Benelli; L., Ottaggio; Mingari, MARIA CRISTINA; S., Zupo; G., Cutrona; Pierri, Ivana; E., Balleari; A., Pattarozzi; M., Calvaruso; C., Tripodo; M., Ferrarini; D., de Totero
Circadian variations of autologous mixed lymphocyte reactions and endogenous cortisol. 1-gen-1985 Indiveri, F; Pierri, Ivana; Rogna, S; Poggi, A; Montaldo, P; Romano, R; Pende, Aldo; Morgano, A; Barabino, A; Ferrone, S.
Combination of liposomal daunorubicin (DaunoXome), fludarabine, and cytarabine (FLAD) in patients with poor-risk acute leukemia. 1-gen-2004 Clavio, M; Venturino, C; Pierri, Ivana; Garrone, A; Miglino, Maurizio; Canepa, L; Balleari, E; Balocco, M; Michelis, Gl; Ballerini, F; Gobbi, Marco
Combination of liposomal Daunorubicin, Fludarabine, and Cytarabine (FLAD) in patients with poor- risk acute leukemia. 1-gen-2004 Clavio, M.; Venturino, C.; Pierri, Ivana; Garrone, A.; Miglino, Maurizio; Canepa, L.; Balleari, E.; Balocco, M.; Michelis, M.; Ballerini, F.; Gobbi, Marco
Cost of de novo acute myeloid leukemia induction therapy in adults: analysis of EORTC-GIMEMA AML10 and FLANG regimens. 1-gen-2001 Clavio, M; Quintino, S; Masoudi, B; Carrara, S; Cerri, R; Pierri, Ivana; Canepa, L; Miglino, Maurizio; Muner, P; Damasio, E; Gobbi, Marco
CTLA-4 expressed by chemoresistant, as well as untreated, myeloid leukaemia cells cdan be targeted with ligands to induce apoptosis 1-gen-2007 Laurent, S; Palmisano, Gl; Martelli, Am; Kato, T; Tazzari, Pl; Pierri, Ivana; Clavio, M; Dozin, B; Balbi, G; Megna, M; Morabito, A; Lamparelli, T; Bacigalupo, A; Gobbi, Marco; Pistillo, Mp
CTLA-4 is not restricted to the lymphoid cell lineage and can function as a target molecule for apoptosis induction of leukemic cells. 1-gen-2003 Pistillo, Mp; Tazzari, Pl; Palmisano, Gl; Pierri, Ivana; Bolognesi, A; Ferlito, F; Capanni, P; Polito, L; Ratta, M; Pileri, S; Piccioli, M; Basso, G; Rissotto, L; Conte, R; Gobbi, Marco; Stirpe, F; Ferrara, Gb